Overview
Faculty
Registration
Agenda
View Archive

Accreditation/
Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie Inc.; Incyte Corporation; PharmaEssentia USA Corporation; and Protagonist Therapeutics.

3rd Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

3rd Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis


September 23, 2021
6:00 - 7:30 PM EDT

Live, Interactive Webcast!

Overview

Optimal management of myeloproliferative neoplasms (MPNs) relies on careful risk stratification and management of symptoms. In recent years, novel treatment options have been introduced to help achieve long-term disease and symptom control, in addition to improving survival.
 
This live Virtual Tumor Board® webcast is specifically designed to meet the needs of busy clinicians who treat patients with MPNs by providing the framework through which these cancers should be diagnosed and managed. Following presentations on current and emerging treatment options for myelofibrosis and polycythemia vera, the faculty will discuss a series of cases constructed to highlight the challenges and solutions with respect to managing MPNs.

Benefits of Attending

  • See discussion of challenging cases of patients with different MPNs
  • Bring your burning clinical questions in MPN management for the experts
  • Expand your toolkit for managing MPNs
  • Engage thought leaders in MPN management on emerging treatment options

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie Inc.; Incyte Corporation; PharmaEssentia USA Corporation; and Protagonist Therapeutics.

Target Audience

This educational activity is directed toward hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with MPNs. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of MPNs may also participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Explain clinical, cytogenetic, and mutation characteristics of MPNs and the potential impact of these factors on risk stratification and treatment decision-making
  • Discuss current strategies for managing patients across the spectrum of MPNs, including those with myelofibrosis (MF) and polycythemia vera (PV)
  • Identify patients with MF and PV who may benefit from participation in clinical trials based on individual and disease characteristics
  • Implement multidisciplinary strategies to mitigate and manage treatment-related toxicities and disease-related symptoms

Hot Topics

  • Emerging JAK inhibitors
  • Novel cytoreductive therapy for PV
  • Treatment-related adverse events
  • Novel combinations of targeted therapy for MF

Program Chair

Ronald Hoffman, MD
Ronald Hoffman, MD
Albert A. and Vera G. List Professor of Medicine
Director, Myeloproliferative Disorders Research Program
Tisch Cancer Institute
Icahn School of Medicine
New York, NY

Registration

2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

Meeting information is accurate at the time of posting.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
2627282930
Filter By